文献速递产科生殖医学

妊娠中晚期阻断白细胞介素11对小鼠母体血压、妊娠存活及后续生育力无影响

Interleukin 11 blockade during mid to late gestation does not affect maternal blood pressure, pregnancy viability or subsequent fertility in mice.
PubMed 文献 · Reprod Biomed Online · 2017-12-19

本研究在小鼠中评估了聚乙二醇化白细胞介素11拮抗剂(PEGIL11A)妊娠中晚期给药的安全性。结果显示,阻断白细胞介素11信号不影响妊娠存活、胎盘或胎儿重量及形态、蜕膜面积、母体血压、尿蛋白或足月幼崽体重;非妊娠小鼠给药后后续生育力、着床位点数、胎盘及胎儿重量与PEG对照组无差异。

要点

  • 妊娠中晚期阻断白细胞介素11信号不影响小鼠妊娠存活及胎盘、胎儿发育。
  • PEGIL11A不改变母体血压、尿蛋白或足月幼崽体重。
  • 非妊娠小鼠给药后后续生育力及着床位点数与对照组无差异。

核心结论

  • 在小鼠中,妊娠中晚期阻断白细胞介素11受体α不影响胎盘、蜕膜、胎儿、母体血压或肾脏。
  • 这些发现提示抑制白细胞介素11信号可能作为缓解子痫前期症状的安全性疗法,并可能作为保留癌症女性生育力的新型疗法。

研究设计与样本

  • 研究在小鼠中评估聚乙二醇化白细胞介素11拮抗剂(PEGIL11A)妊娠中晚期给药的安全性。

主要发现

  • 妊娠中晚期阻断白细胞介素11信号不影响妊娠存活,不改变胎盘或胎儿重量及形态。
  • 蜕膜面积保持不变。
  • PEGIL11A不影响母体血压、尿蛋白或足月幼崽体重。
  • 非妊娠小鼠给予PEGIL11A后不影响后续生育力,PEGIL11A组与PEG对照组在着床位点数、胎盘或胎儿重量上无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Interleukin (IL)11 is a crucial regulator during the initiation of pregnancy in humans and mice. Elevated levels are detected in serum, placenta and decidua of women with pre-eclampsia. Elevated IL11 during placentation recapitulates pre-eclampsia in mice, although withdrawal rescues pre-eclampsia features, suggesting that IL11 could provide a novel therapeutic target. The aim of this study was to determine the safety profile of an IL11 antagonist ligated to polyethylene glycol (PEGIL11A) during pregnancy in mice. Blocking IL11 signalling during mid to late gestation pregnancy in mice did not affect pregnancy viability, or alter placental or fetal weight, or morphology. Importantly, decidual area remained unchanged. PEGIL11A did not affect maternal blood pressure, urinary protein or term pup weight. PEGIL11A administration to non-pregnant mice did not affect subsequent fertility; there was no difference in number of implantation sites, or placental or fetal weight between PEGIL11A and PEG-treated mice. These data show that blocking IL11Rα during placentation does not alter the placenta, decidua, fetus, maternal blood pressure or kidneys. These findings highlight the potential of IL11 signalling inhibition as a safe therapy to alleviate pre-eclampsia symptoms and demonstrate the potential for IL11 inhibition as a novel fertility-preserving therapy for women with cancer.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Winship A, Menkhorst E, Van Sinderen M, et al. Interleukin 11 blockade during mid to late gestation does not affect maternal blood pressure, pregnancy viability or subsequent fertility in mice. Reprod Biomed Online. 2017. PMID: 29361454. doi:10.1016/j.rbmo.2017.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。